Clinical Trials Directory

Trials / Completed

CompletedNCT06167616

Infections and Latent Autoimmune Diabetes in Adults

Infections and Genetic Susceptibility in LADA and Type 2 Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
5,048 (actual)
Sponsor
Karolinska Institutet · Academic / Other
Sex
All
Age
35 Years
Healthy volunteers
Accepted

Summary

Infections are proposed risk factors for type 1 diabetes in children. The investigators will examine whether a diagnosis of infectious disease also confers an increased risk of latent autoimmune diabetes in adults.

Detailed description

The investigators will use data from a population-based Swedish case-control study (ESTRID) with incident cases of LADA (n=597) and matched controls (n=2386). History of infectious disease are ascertained through national and regional patient registers. The investigators will estimate adjusted odds ratios (OR) with 95% CI for ≥1 respiratory (any/upper/lower), gastrointestinal, herpetic, other or any infectious disease episode, or separately, for 1 and ≥2 infectious disease episodes, within 0-1, 1-3, 3-5 and 5-10 years before LADA diagnosis/matching. Stratified analyses will be performed based on HLA risk genotypes and GADA levels.

Conditions

Timeline

Start date
2010-09-01
Primary completion
2019-10-31
Completion
2019-10-31
First posted
2023-12-12
Last updated
2023-12-12

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT06167616. Inclusion in this directory is not an endorsement.